JBM Auto Ltd
JBM Auto Limited has informed the exchange regarding a Press Release dated 4th November 2026
JBM Auto Ltd has announced the launch of its new electric city bus, ECOLIFE e12, at Singapore Urban Mobility Week 2026.
BSE & NSE corporate filings with AI summaries
JBM Auto Ltd
JBM Auto Ltd has announced the launch of its new electric city bus, ECOLIFE e12, at Singapore Urban Mobility Week 2026.
Keystone Realtors Limited
Keystone Realtors Limited has announced its unaudited financial results for Q2FY27, with highest ever quarterly pre-sales of INR 14.23 billion, up 84% YoY, and highest ever quarterly PAT of INR 1.01 billion.
CL Educate Ltd
CL Educate Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2026, with a 13.2% increase in EBITDA and a 289 bps expansion in EBITDA margin.
Exide Industries Limited
Exide Industries Limited has announced its Q2 FY27 financial results, with revenue growth of 18.9% and PAT growth of 46.7%. The company has also commissioned 6 GWh of Lithium-ion Cell Gigafactory.
Exide Industries Ltd
Exide Industries Ltd reported Q2 FY27 revenue growth of 20.3% YoY to Rs. 5,026 Crore, with PAT growth of 75.1% YoY to Rs. 386 Crore. The company commissioned 6 GWh of Lithium-ion Cell Gigafactory.
Keystone Realtors Ltd
Keystone Realtors Ltd reported its unaudited financial results for Q2FY27, with highest ever quarterly pre-sales of INR 14.23 billion, up 84% YoY, and highest ever quarterly PAT of INR 1.01 billion. The company achieved 41% of its full-year FY27 pre-sales guidance within the first half of FY27.
JBM Auto Limited
JBM Auto Limited has announced the launch of its new electric city bus, ECOLIFE e12, at Singapore Urban Mobility Week 2026.
Sundaram Clayton Limited
Sundaram Clayton Limited has reported strong performance in Q2 FY27 with a 37% growth in standalone revenue and a 96% rise in PAT.
Sundaram-Clayton Ltd
Sundaram-Clayton Ltd reported strong Q2 FY27 performance with 37% revenue growth and 96% PAT rise, driven by broad-based customer growth and robust export demand.
Ester Industries Ltd
Ester Industries Ltd reported strong Q2FY27 performance with Revenue growth of 25.7%, EBITDA up by 160.0% Y-o-Y, and Margins improve by approximately 510 bps. The company's consolidated Total Income increased 25.7% Y-o-Y to ₹449.0 crores, while EBITDA more than doubled, rising 160% Y-o-Y to ₹45.1 crores.
Multi Commodity Exchange of India Ltd
Multi Commodity Exchange of India Ltd has released its Q2 FY27 investor presentation, showcasing steady growth momentum with total income, EBITDA, and profit after tax increasing by 98.6%, 121.3%, and 116.4% YoY respectively.
GlaxoSmithKline Pharmaceuticals Ltd
GlaxoSmithKline Pharmaceuticals Ltd has announced its Q2 FY27 financial results, with revenue growth of 21%, EBITDA margin of 34%, and PAT margin of 33%. The company's key brands have maintained their competitive performance in the market.
Ester Industries Limited
Ester Industries Limited has reported strong Q2FY27 performance with Revenue growth of 25.7%, EBITDA up by 160.0% Y-o-Y, and Margins improve by approximately 510 bps. The company has also announced its unaudited financial results for the half year ended 30th September 2026.
GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Investor Presentation, highlighting its growth momentum, key focus areas, and financial highlights for Q2 FY27.
Ester Industries Ltd
Ester Industries Ltd has announced its un-audited financial results for Q2 and H1 FY27, showing a 25.7% YoY increase in consolidated income to ₹449 Cr and a 160% YoY increase in EBITDA to ₹45.1 Cr. The company has also provided an update on its ELITe project, with various aspects progressing well and acquisition of land expected to be completed by Q4FY27.
Ester Industries Limited
Ester Industries Limited has informed the Exchange about Investor Presentation on Un-Audited Financial Results for the quarter and half year ended on 30th September 2026, showing a 25.7% YoY increase in consolidated income to ₹449 Cr in Q2FY27 and a 26.5% YoY growth to ₹891 crore in H1FY27, driven by strong operating performance in the Polyester Films business.
Kwality Pharmaceuticals Ltd
Kwality Pharmaceuticals Ltd has secured EU-GMP approval from Hungary for its Cephalosporin and Oncology facilities, expanding its EU-GMP-approved manufacturing capabilities and creating substantial business opportunities.
Motherson Sumi Wiring India Limited
Motherson Sumi Wiring India Limited has announced its Q2 FY'27 results, with revenue growing 47% year-on-year and 19% sequentially, and EBITDA increasing 34% year-on-year and 45% sequentially.
Saregama India Ltd
Saregama India Ltd reported Q2 FY 2026-27 financial results with 37% YoY revenue growth, 39% YoY EBITDA growth, and 43% YoY PBT growth. Music revenue grew 35% YoY, while live events revenue grew 101% YoY.
Motherson Sumi Wiring India Ltd
Motherson Sumi Wiring India Ltd reported a 47% year-on-year and 19% sequential revenue growth in Q2 FY'27, driven by higher customer volume, new program launches, and contributions from Greenfield plants. EBITDA increased 34% year-on-year and 45% sequentially, while profit after tax registered growth of 35% and 54% respectively.